Drug Approvals
🇺🇸 FDA Page 39FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 457–468 of 665 articles
Global Preparedness: Lessons from Hantavirus and Ebola Outbreaks
Takeda Settles Kickback Allegations: What It Means for Pharma
Aardvark's Next Move After Clinical Hold: Alumis' Verdict on Acelyrin
New Ebola Outbreak in Congo: Implications for Pharma
Amgen's Expanded Crackdown on 340B Program Misuse
#ASGCT26: Zillow-like Marketplace for Abandoned Gene Therapies
Eisai's Leqembi Sales Forecast: A Closer Look at $900M Potential
Holland & Knight Health Dose: Oncology Updates from May 12, 2026
Political Contest in the U.K. Could Shake Up Drug Pricing
Biotech Leaders Push for Pazdur Amid Takeda Layoffs
NICE Approval for Imfinzi: Implications for Stomach Cancer Treatment
US Cancer Clinics Rush for Revolution Medicines' New Pancreatic Cancer Drug